<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02856087</url>
  </required_header>
  <id_info>
    <org_study_id>YSjeon_naloxone</org_study_id>
    <nct_id>NCT02856087</nct_id>
  </id_info>
  <brief_title>The Effect of Ultra-low-dose Naloxone on Remifentanil-induced Postoperative Hyperalgesia - A Randomized Controlled Study</brief_title>
  <official_title>The Effect of Ultra-low-dose Naloxone on Remifentanil-induced Postoperative Hyperalgesia - A Randomized Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      High-dose remifentanil infused intraoperative ironically results in postoperative
      hyperalgesia. Ultra-low dose nalxone is demonstrated to prevent these opioid-induced
      hyperalgesia in animal model. In this clinical trial in patients undergoing general
      anesthesia with remifentanil, we evaluate the effects of ultra-low-dose naloxone on
      remifentanil-induced hyperalgesia
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      We enrolled adult patients undergoing thyroidectomy under general anesthesia with desflurane
      and remifentanil. Remifentanil was administered via target-controlled infusion and anesthetic
      depth was maintained keeping the BIS between 40 and 60. Patients were randomized into one of
      three groups depending on intraoperative doses of remifentanil and naloxone: effect-site
      concentrations of remifentanil 1 ng/ml (control group), 4 ng/ml (remifentanil group), and 4
      ng/ml combined with infusion rate 0.8 ng/kg/min of naloxone (remifentanil and naloxone
      group). Postoperative mechanical pain thresholds, pain intensity, and analgesic consumption
      were examined during 48 h of postoperative period. The primary outcome was mechanical pain
      threshold measured on the peri-incisional area 24 h after surgery.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2014</start_date>
  <completion_date type="Actual">April 2015</completion_date>
  <primary_completion_date type="Actual">April 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mechanical pain thresholds</measure>
    <time_frame>24hr after surgery</time_frame>
    <description>Mechanical pain thresholds were assessed by von Frey filaments. The patients were asked to close their eyes during the test, and an investigator made the filament pressing the skin perpendicularly against the skin until bowing and being maintained for 1.5 seconds. The filament size was started from 0.4 g and was increased to the point until the patient perceives a clear change in sensation.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mechanical pain thresholds</measure>
    <time_frame>48hr after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>pain score</measure>
    <time_frame>verbal numerical rating scale at 24 hr after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>pain score</measure>
    <time_frame>verbal numerical rating scale at 48 after surgery</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">92</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>group LR</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>low dose remifentanil (1 ng/ml of Ce) with normal saline infusion</description>
  </arm_group>
  <arm_group>
    <arm_group_label>group HR</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>High dose remifentanil infusion (4ng/ml of Ce) with normal saline infusion</description>
  </arm_group>
  <arm_group>
    <arm_group_label>group HR-N</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>remifentanil infusion at 4ng/ml of Ce with naloxone infusion</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>High dose Remifentanil</intervention_name>
    <description>remifentanil infusion at 4ng/ml of Ce</description>
    <arm_group_label>group HR</arm_group_label>
    <arm_group_label>group HR-N</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Naloxone</intervention_name>
    <description>naloxone infusion</description>
    <arm_group_label>group HR-N</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Low dose remifentanil</intervention_name>
    <description>remifentanil infusion at 1ng/ml of Ce</description>
    <arm_group_label>group LR</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Normal Saline</intervention_name>
    <description>normal saline infusion</description>
    <arm_group_label>group LR</arm_group_label>
    <arm_group_label>group HR</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients who are scheduled to undergo elective thyroidectomy

        Exclusion Criteria:

          -  consent refusal, obesity, pregnancy, hx. of thyroid surgery, neurological disorders,
             psychiatric disorders, hx. of drug abuse or chronic use of opioids or sedative drugs,
             intake of any analgesic drug within 12h before surgery.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yunseok Jeon, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 2, 2016</study_first_submitted>
  <study_first_submitted_qc>August 2, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 4, 2016</study_first_posted>
  <last_update_submitted>November 15, 2016</last_update_submitted>
  <last_update_submitted_qc>November 15, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 16, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Yunseok Jeon</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>acute pain</keyword>
  <keyword>postoperative</keyword>
  <keyword>surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperalgesia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Remifentanil</mesh_term>
    <mesh_term>Naloxone</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

